Literature DB >> 17021355

Biomarkers in acute exacerbation of chronic obstructive pulmonary disease: among the blind, the one-eyed is king.

Beat Müller, Michael Tamm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17021355     DOI： 10.1164/rccm.200607-922ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

2.  Trends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation.

Authors:  Islem Ouanes; Lamia Ouanes-Besbes; Saoussen Ben Abdallah; Fahmi Dachraoui; Fekri Abroug
Journal:  Ann Intensive Care       Date:  2015-10-01       Impact factor: 6.925

3.  How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study.

Authors:  Johanna Laue; Hasse Melbye; Peder A Halvorsen; Elena A Andreeva; Maciek Godycki-Cwirko; Anja Wollny; Nick A Francis; Mark Spigt; Kenny Kung; Mette Bech Risør
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-08

4.  Inference of Cellular Immune Environments in Sputum and Peripheral Blood Associated with Acute Exacerbations of COPD.

Authors:  Katy C Norman; Christine M Freeman; Neha S Bidthanapally; MeiLan K Han; Fernando J Martinez; Jeffrey L Curtis; Kelly B Arnold
Journal:  Cell Mol Bioeng       Date:  2019-03-15       Impact factor: 2.321

5.  Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease.

Authors:  Takashi Angata; Takeo Ishii; Congxiao Gao; Kazuaki Ohtsubo; Shinobu Kitazume; Akihiko Gemma; Kozui Kida; Naoyuki Taniguchi
Journal:  Physiol Rep       Date:  2014-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.